Mysterious Virus : A Review on Behavior and Treatment Approaches of the Novel Coronavirus, 2019-nCoV
Copyright © 2020 IMSS. Published by Elsevier Inc. All rights reserved..
At the end of the year 2019, the novel coronavirus (2019-nCoV) was spreading in Wuhan, China, and the outbreak process has a high speed. It was recognized as a pandemic by the World Health Organization (WHO) on 11 March 2020. Coronaviruses are enveloped and single-stranded RNA that have several families including Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). The pathogenesis mechanism and disease outcomes of SARS and MERS are now clear to some extent, but little information is available for 2019-nCoV. This newly identified corona virus infection represents flu-like symptoms, but usually the first symptoms are fever and dry cough. There has been no specific treatment against 2019-nCoV up to now, and physicians only apply supportive therapy. In the present article, we made an attempt to review the behavior of the virus around the world, epidemiology, a pathway for influx into the host cells, clinical presentation, as well as the treatments currently in use and future approaches; nitazoxanide may be our dream drug. We hope that this review has a positive impact on public knowledge for helping to deal with the 2019-nCoV and move one step forward toward its treatment in the near future.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:51 |
|---|---|
| Enthalten in: |
Archives of medical research - 51(2020), 5 vom: 01. Juli, Seite 375-383 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hemmati, Farshad [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
2019-nCoV |
|---|
| Anmerkungen: |
Date Completed 01.07.2020 Date Revised 13.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.arcmed.2020.04.022 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM310306647 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM310306647 | ||
| 003 | DE-627 | ||
| 005 | 20231225135818.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.arcmed.2020.04.022 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1034.xml |
| 035 | |a (DE-627)NLM310306647 | ||
| 035 | |a (NLM)32448490 | ||
| 035 | |a (PII)S0188-4409(20)30550-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hemmati, Farshad |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Mysterious Virus |b A Review on Behavior and Treatment Approaches of the Novel Coronavirus, 2019-nCoV |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.07.2020 | ||
| 500 | |a Date Revised 13.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020 IMSS. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a At the end of the year 2019, the novel coronavirus (2019-nCoV) was spreading in Wuhan, China, and the outbreak process has a high speed. It was recognized as a pandemic by the World Health Organization (WHO) on 11 March 2020. Coronaviruses are enveloped and single-stranded RNA that have several families including Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). The pathogenesis mechanism and disease outcomes of SARS and MERS are now clear to some extent, but little information is available for 2019-nCoV. This newly identified corona virus infection represents flu-like symptoms, but usually the first symptoms are fever and dry cough. There has been no specific treatment against 2019-nCoV up to now, and physicians only apply supportive therapy. In the present article, we made an attempt to review the behavior of the virus around the world, epidemiology, a pathway for influx into the host cells, clinical presentation, as well as the treatments currently in use and future approaches; nitazoxanide may be our dream drug. We hope that this review has a positive impact on public knowledge for helping to deal with the 2019-nCoV and move one step forward toward its treatment in the near future | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a 2019-nCoV | |
| 650 | 4 | |a Infection | |
| 650 | 4 | |a Novel coronavirus | |
| 650 | 4 | |a Respiratory problem | |
| 650 | 4 | |a Treatment approach | |
| 650 | 7 | |a Nitro Compounds |2 NLM | |
| 650 | 7 | |a Thiazoles |2 NLM | |
| 650 | 7 | |a nitazoxanide |2 NLM | |
| 650 | 7 | |a SOA12P041N |2 NLM | |
| 700 | 1 | |a Saedi, Samira |e verfasserin |4 aut | |
| 700 | 1 | |a Hemmati-Dinarvand, Mohsen |e verfasserin |4 aut | |
| 700 | 1 | |a Zarei, Marzie |e verfasserin |4 aut | |
| 700 | 1 | |a Seghatoleslam, Atefeh |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Archives of medical research |d 1996 |g 51(2020), 5 vom: 01. Juli, Seite 375-383 |w (DE-627)NLM012656291 |x 1873-5487 |7 nnns |
| 773 | 1 | 8 | |g volume:51 |g year:2020 |g number:5 |g day:01 |g month:07 |g pages:375-383 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.arcmed.2020.04.022 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 51 |j 2020 |e 5 |b 01 |c 07 |h 375-383 | ||